Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients

INTRODUCTION: Ovarian cancer (OV) can seriously endanger women’s physical and mental health. Serum DKK3 has been used for the diagnosis and prognosis of patients with ovarian cancer. However, the specificity of antibodies may lead to errors in the detection of plasma protein. METHODS: Circulating CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Xiao-Cui, He, Fang, Lan, Chong, Niu, Ju-Min, Xia, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814242/
https://www.ncbi.nlm.nih.gov/pubmed/33488097
http://dx.doi.org/10.2147/OTT.S288191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814242/
https://www.ncbi.nlm.nih.gov/pubmed/33488097
http://dx.doi.org/10.2147/OTT.S288191

Ejemplares similares